Evidence map›Paper›PMID 40348949›Full record

ArticleBMC cardiovascular disorders2025

Risk factors and predictive models for post-operative moderate-to-severe mitral regurgitation following transcatheter aortic valve replacement: a machine learning approach.

Zhenzhen Li, Jianing Fan, Jiajun Fan, Jiaxin Miao, Dawei Lin, Jingyan Zhao, Xiaochun Zhang, Wenzhi Pan, Daxin Zhou, Junbo Ge

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Recent advances in omics-based research of mitral valve disease.Frontiers in cardiovascular medicine · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhenzhen Li *School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jianing Fan *Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.
Jiajun Fan *Chongqing University, Chongqing, 400030, China.
Jiaxin MiaoDepartment of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.
Dawei LinDepartment of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.
Jingyan ZhaoDepartment of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xiaochun ZhangDepartment of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.
Wenzhi PanDepartment of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China. peden@sina.com.
Daxin ZhouSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China. daxin_zhou@163.com.
Junbo GeDepartment of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.

Funding

National Natural Science Foundation of China T2288101
6 · The paper itself

Abstract

backgroundPost-operative moderate-to-severe mitral regurgitation (MR) following transcatheter aortic valve replacement (TAVR) is associated with poor outcomes, yet the factors contributing to this complication are not well understood. This study aimed to identify risk factors and develop predictive models for post-operative MR following TAVR using machine learning (ML) techniques to enhance early detection and intervention.

methodsWe retrospectively analyzed data from patients who underwent TAVR at our center between August 2014 and August 2023. Patients were classified into post-operative and nonpost-operative MR groups based on postprocedural MR severity. Various ML models were evaluated for predictive performance using metrics such as accuracy, precision, recall, F1 score, and area under the receiver operating characteristic curve (AUC). Shapley Additive Explanation (SHAP) values were used to interpret predictive patterns and develop a clinically relevant model.

resultsAmong the evaluated models, the random forest model exhibited the highest predictive performance for post-operative moderate-to-severe MR after TAVR. Key predictors, which were confirmed by the SHAP analysis as important in the predictive framework, included echocardiographic parameters, blood test results, patient age, and body mass index.

conclusionsML models show promise in predicting post-operative moderate-to-severe MR after TAVR by integrating clinical indicators to enhance predictive accuracy. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Aortic Valve StenosisDecision Support TechniquesMachine LearningMitral ValveMitral Valve InsufficiencyTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMalePredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexAortic stenosis (AS)Machine learningMitral regurgitation (MR)Predictive modelTranscatheter aortic valve replacement (TAVR)

Identifiers

PMID40348949
PMCPMC12065341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.